Tue, September 13, 2011
Mon, September 12, 2011
Sat, September 10, 2011
Fri, September 9, 2011
Thu, September 8, 2011
Wed, September 7, 2011
Tue, September 6, 2011
Mon, September 5, 2011
Sat, September 3, 2011
Fri, September 2, 2011
Thu, September 1, 2011
Wed, August 31, 2011
Tue, August 30, 2011
Mon, August 29, 2011
Fri, August 26, 2011
Thu, August 25, 2011
Wed, August 24, 2011
Tue, August 23, 2011
Mon, August 22, 2011
Sat, August 20, 2011
Fri, August 19, 2011
Thu, August 18, 2011
Wed, August 17, 2011
Tue, August 16, 2011
Mon, August 15, 2011
[ Mon, Aug 15th 2011 ]: Market Wire
30 PM EDT
Sat, August 13, 2011
Fri, August 12, 2011
Thu, August 11, 2011
Wed, August 10, 2011
Tue, August 9, 2011
Mon, August 8, 2011
Sat, August 6, 2011
Fri, August 5, 2011
Thu, August 4, 2011
Wed, August 3, 2011
Tue, August 2, 2011
[ Tue, Aug 02nd 2011 ]: Market Wire
New South Wales Acquisition
Mon, August 1, 2011
Sun, July 31, 2011
Fri, July 29, 2011
Thu, July 28, 2011
Wed, July 27, 2011
Tue, July 26, 2011
Mon, July 25, 2011
Sun, July 24, 2011
Sat, July 23, 2011
Fri, July 22, 2011
Thu, July 21, 2011
Wed, July 20, 2011
Tue, July 19, 2011
Mon, July 18, 2011
Fri, July 15, 2011
[ Fri, Jul 15th 2011 ]: Market Wire
PepsiCo Declares Dividend
Thu, July 14, 2011

TrovaGene, Inc. confirma que ha vuelto a obtener la propiedad de sus derechos de la tecnologa transrenal para pruebas prenatale

  Copy link into your clipboard //house-home.news-articles.net/content/2011/08/1 .. tecnologa-transrenal-para-pruebas-prenatale.html
  Print publication without navigation Published in House and Home on by Market Wire
          🞛 This publication is a summary or evaluation of another publication

SAN DIEGO--([ BUSINESS WIRE ])--TrovaGene, Inc. (Pink Sheets: TROV), un desarrollador de diagnsticos moleculares transrenales, ha confirmado hoy que ha vuelto a obtener el control y la propiedad de sus derechos mundiales de su patente de tecnologa transrenal para aplicaciones prenatales no invasivas y cncer mediante la conclusin de un acuerdo de licencia entre TrovaGene y Sequenom, Inc. En 2008, TrovaGene otorg la licencia de algunas de sus patentes a Sequenom para el desarrollo de aplicaciones de screening y diagnstico prenatal de forma exclusiva. En 2009, TrovaGene entabl una demanda contra Sequenom en la que alegaba fraude y solicitaba que se le devolvieran sus derechos otorgados por licencia a Sequenom.

El comunicado en el idioma original, es la versin oficial y autorizada del mismo. La traduccin es solamente un medio de ayuda ydeber sercomparada con el texto en idioma original, que es la nica versin del texto que tendr validez legal.